N-[(4-Fluorophenyl)methyl]-1-(N'-hydroxycarbamimidoyl)formamide

Catalog No. :
ACLSRJ425
CAS No. :
1049607-08-0
Molecular Formula :
C9H10FN3O2
Molecular Weight :
211.20

IUPAC Name:2-amino-N-(4-fluorobenzyl)-2-(hydroxyimino)acetamide

N-[(4-Fluorophenyl)methyl]-1-(N'-hydroxycarbamimidoyl)formamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$84.00Login to see priceInquiryInquiry
100mg95%$120.00Login to see priceInquiryInquiry
250mg95%$163.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(4-Fluorophenyl)methyl]-1-(N'-hydroxycarbamimidoyl)formamide
IUPAC Name2-amino-N-(4-fluorobenzyl)-2-(hydroxyimino)acetamide
MDL No.MFCD10686939
Molecular FormulaC9H10FN3O2
Molecular Weight211.20
SMILESO=C(/C(N)=N/O)NCC1=CC=C(F)C=C1
InChI KeyWSCMIQOBEDNEGN-UHFFFAOYSA-N
SynonymN-[(4-fluorophenyl)methyl]-1-(N'-hydroxycarbamimidoyl)formamide;Acetamide, N-[(4-fluorophenyl)methyl]-2-(hydroxyamino)-2-imino-
CAS No.1049607-08-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACLSRJ425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLGWV132 route compound structure diagram
    ACLGWV13210489-74-4 In Stock
  2. Plus
  3. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6 In Stock
  4. Then
  5. ACLSRJ425 route product structure diagram
    ACLSRJ4251049607-08-0
Inquiry

2. ACLSRJ425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6 In Stock
  4. Then
  5. ACLSRJ425 route product structure diagram
    ACLSRJ4251049607-08-0
Inquiry

Comments (0)